NASDAQ:CODX - Co-Diagnostics Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$2.63 -0.12 (-4.36 %)
(As of 09/21/2018 04:00 PM ET)
Previous Close$2.63
Today's Range$2.63 - $2.80
52-Week Range$1.45 - $6.85
Volume23,303 shs
Average Volume383,148 shs
Market Capitalization$26.78 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. Co-Diagnostics, Inc. was founded in 2013 and is headquartered in Salt Lake City, Utah.

Receive CODX News and Ratings via Email

Sign-up to receive the latest news and ratings for CODX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:CODX
CUSIPN/A
Phone+1-801-2789769

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-149,750.40%
Return on Equity-3,935.44%
Return on Assets-479.06%

Miscellaneous

EmployeesN/A
Outstanding Shares11,920,000
Market Cap$26.78 million

Co-Diagnostics (NASDAQ:CODX) Frequently Asked Questions

What is Co-Diagnostics' stock symbol?

Co-Diagnostics trades on the NASDAQ under the ticker symbol "CODX."

Who are some of Co-Diagnostics' key competitors?

Who are Co-Diagnostics' key executives?

Co-Diagnostics' management team includes the folowing people:
  • Mr. Dwight H. Egan, Chairman, CEO & Pres (Age 65)
  • Dr. Brent C. Satterfield, Co-Founder, Chief Science Officer & Director (Age 41)
  • Mr. Reed L. Benson, CFO, Gen. Counsel & Sec. (Age 70)

When did Co-Diagnostics IPO?

(CODX) raised $9 million in an initial public offering (IPO) on Thursday, July 13th 2017. The company issued 1,300,000 shares at $6.35-$6.75 per share. WallachBeth Capital and Network 1 Securities acted as the underwriters for the IPO.

How do I buy shares of Co-Diagnostics?

Shares of CODX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Co-Diagnostics' stock price today?

One share of CODX stock can currently be purchased for approximately $2.63.

How big of a company is Co-Diagnostics?

Co-Diagnostics has a market capitalization of $26.78 million.

What is Co-Diagnostics' official website?

The official website for Co-Diagnostics is http://codiagnostics.com/.

How can I contact Co-Diagnostics?

Co-Diagnostics' mailing address is 4049 S Highland Dr, SALT LAKE CITY, UT 84124-1664, United States. The company can be reached via phone at +1-801-2789769.


MarketBeat Community Rating for Co-Diagnostics (NASDAQ CODX)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  106 (Vote Outperform)
Underperform Votes:  102 (Vote Underperform)
Total Votes:  208
MarketBeat's community ratings are surveys of what our community members think about Co-Diagnostics and other stocks. Vote "Outperform" if you believe CODX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CODX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel